The Use Of Selegiline To Treat Fatigue In Patients With Parkinson's Disease

Clinical Trial Investigator: Cindy Zadikoff, MD

Aim: This study will look at the efficacy of Selegiline to treat fatigue in patients with Parkinson's Disease.

Procedures: Treatment with either selegilne or placebo, completion of questionnaires regarding fatigue during four clinic visits.

Study Duration: 14 weeks

Compensation: Parking voucher will be provided

ALL STUDY RELATED MEDICATION/PROCEDURES ARE FREE OF CHARGE.

For More Information: Call us at (312) 503-0755, or email pdclinicaltrials@northwestern.edu.

Disclaimer

Northwestern Medicine and Northwestern University Feinberg School of Medicine will not release any of your personal information to 3rd parties, participating organizations and/or other institutions. Your information will only be available to the researcher(s) after you indicate interest in being contacted about a particular study.

Newly Diagnosed

Newly diagnosed with Parkinson’s disease and not yet treated? Please complete the Northwestern Medicine Parkinson’s Disease and Movement Disorders Center online appointment form to discuss next steps.

Feinberg is not a site of care. PDMDC faculty see patients through our affiliated clinic.